User: Guest  Login
Document type:
Meeting Abstract
Author(s):
Lordick, F.; Buxo Orra, E.; Cervantes, A.; Dayyani, F.; Rocha-Lima, C.; Greil, R.; van Laarhoven, H.; Lorenzen, S.; Kischel, R.; Shitara, K.; Chao, J.
Title:
A phase 1 study of AMG 199, a half-life extended bispecific T-cell engager (HLE BiTE (R)) immune therapy, targeting MUC17 in patients with gastric and gastroesophageal junction cancer
Journal title abbreviation:
Ann Oncol
Year:
2020
Journal volume:
31 Suppl 3
Pages contribution:
S114-S114
Fulltext / DOI:
doi:10.1016/j.annonc.2020.04.158
Print-ISSN:
0923-7534
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX